Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V R Cicinnati

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Transplantation Proceedings|July 15, 2004
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, X Zhang, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|August 5, 2011
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experienceS Vernadakis, Georgios C Sotiropoulos, E I Brokalaki, et al.
Transplantation Proceedings|March 3, 2009
Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell linesM Heuer, T Benkö, V R Cicinnati, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoringV R Cicinnati, Z Yu, C G Klein, et al.
Transplantation Proceedings|November 18, 2008
Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resectionS Beckebaum, X Chen, G C Sotiropoulos, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2007
Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantationV R Cicinnati, S Iacob, C G Klein, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|August 25, 2007
Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issuesG C Sotiropoulos, S Beckebaum, H Lang, et al.
Transplantation Proceedings|November 18, 2008
A new systematic classification of peripheral anatomy of the right hepatic duct: experience from adult live liver donor transplantationA Radtke, G Sgourakis, G C Sotiropoulos, et al.
Transplantation Proceedings|November 18, 2008
Hepatic hilar and sectorial vascular and biliary anatomy in right graft adult live liver donor transplantationA Radtke, G Sgourakis, G C Sotiropoulos, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Transplantation Proceedings|July 15, 2004
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, X Zhang, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|August 5, 2011
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experienceS Vernadakis, Georgios C Sotiropoulos, E I Brokalaki, et al.
Transplantation Proceedings|March 3, 2009
Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell linesM Heuer, T Benkö, V R Cicinnati, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoringV R Cicinnati, Z Yu, C G Klein, et al.
Transplantation Proceedings|November 18, 2008
Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resectionS Beckebaum, X Chen, G C Sotiropoulos, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2007
Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantationV R Cicinnati, S Iacob, C G Klein, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|August 25, 2007
Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issuesG C Sotiropoulos, S Beckebaum, H Lang, et al.
Transplantation Proceedings|November 18, 2008
A new systematic classification of peripheral anatomy of the right hepatic duct: experience from adult live liver donor transplantationA Radtke, G Sgourakis, G C Sotiropoulos, et al.
Transplantation Proceedings|November 18, 2008
Hepatic hilar and sectorial vascular and biliary anatomy in right graft adult live liver donor transplantationA Radtke, G Sgourakis, G C Sotiropoulos, et al.
Pageof 3